Leslie V Norwalk

CIK 1533568 · last filed 2026-07-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.14M

Companies

13

Total Filings

88

Lifetime Open-Market Net

-$4.39M

Filer Profile

Reported Address
C/O 3661 VALLEY CENTRE DRIVE SUITE 200
SAN DIEGO, CA 92130
Related Filers
NEUROCRINE BIOSCIENCES INC — 20 joint filings, latest 2026-07-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NBIX Director 2,430 $148.48 $360.8K -$3.22M 15 2026-07-30
ARVN Director 41,572 $8.22 $341.9K $0 8 2026-06-26
CVS Director 7,376 $88.32 $651.4K $0 4 2026-05-15
GMED Director 10,419 $74.59 $777.2K -$1.18M 8 2026-01-23
ModivCare Inc (MODV) Delisted Director 18,830 $0.44 $8.3K $0 4 2024-02-16
NUVASIVE INC (NUVA) Delisted Director 0 $39.75 $0 $0 12 2023-09-05
CENTENE CORP (CNTE) Delisted Director 1,481 $0 2 2022-04-04
MAGELLAN HEALTH INC (MGLN) Delisted Director 0 $94.99 $0 $0 3 2022-01-04
ModivCare Inc (PRSC) Delisted Director 12,910 $0 6 2020-02-18
ENDOLOGIX INC /DE/ (ELGX) Delisted Director 29,932 $0 5 2019-08-06
NKTR Director 186 $68.72 $12.8K $0 2 2019-06-24
Press Ganey Holdings, Inc. (PGND) Delisted Director 0 $0 3 2016-10-25
Volcano Corp (VOLC) Delisted Director 4,958 $0 7 2014-10-27

Recent Filings · Page 3 of 9

88 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-11-25 CVS Grant (A) +2,200 $125.6K EDGAR
2024-07-15 GMED Sell (S) −1,000 -$70.0K EDGAR
2024-07-11 GMED Notice (144) −1,000 -$70.0K EDGAR
2024-05-31 ARVN Grant (A) +5,899 $0 EDGAR
2024-05-23 NBIX Grant (A) $0 EDGAR
2024-05-21 NBIX Mixed +994 -$156.8K EDGAR
2024-05-17 NBIX Notice (144) −1,106 -$157.0K EDGAR
2024-03-19 GMED Sell (S) −10,590 -$550.6K EDGAR
2024-03-15 GMED Notice (144) −10,590 -$550.0K EDGAR
2024-02-29 NBIX Mixed -$405.8K EDGAR
Showing 2130 of 88
Page 3 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.